The DOI matches its Crossref record; the references it cites are not checked yet.
Hyperglycemia following Intralesional Corticosteroid Injection in a Patient with Type I Diabetes Mellitus
Abstract
Case Report: A 36-year-old woman with well-controlled type 1 diabetes mellitus reported hyperglycemia (plasma glucose peaked at 21.3 mmol/L) after her first injection with intralesional triamcinolone acetonide for alopecia areata. Conclusion: Intralesional corticosteroids are used to maximize local effect while presumably minimizing systemic complications. This adverse effect is an important consideration when treating patients with insulin-dependent diabetes mellitus, and it would be reasonable to counsel patients of such a possibility.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists are queued
They are fetched later and appear here then.
References 5 · Cited by 7
Metadata
- Authors
- Fleming, P., Drazek, L., & Shaw, J. C.
- Affiliations
- University of Toronto (CA)
- Venue
- Journal of Cutaneous Medicine and Surgery
- Publisher
- SAGE Publications
- Published
- 2014-07
- Volume
- 18
- Issue
- 4
- Pages
- 275-276
- ISSN
- 1203-4754 (ISSN-L)
- 1615-7109
- OpenAlex
- W2040738767
- Cited by
- 7
- References
- 5
- Citations by year
- 2026: 2 · 2022: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2014: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cutaneous Medicine and Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperglycemia, intralesional corticosteroid injection, triamcinolone acetonide, type 1 diabetes, alopecia areata, adverse drug reactions, systemic corticosteroid effects, patient counseling
- MeSH terms
- Adult, Alopecia Areata, Diabetes Mellitus, Type 1, Female, Glucocorticoids, Humans, Hyperglycemia, Triamcinolone Acetonide, Injections, Intralesional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hyperglycemia following Intralesional Corticosteroid Injection in a Patient with Type I Diabetes Mellitus. https://app.cochat.ai/papers/10.2310/7750.2013.13128
- The paper
- Fleming, P., Drazek, L., & Shaw, J. C. (2014). Hyperglycemia following Intralesional Corticosteroid Injection in a Patient with Type I Diabetes Mellitus. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.2310/7750.2013.13128
